The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology (한방안이비인후피부과학회지)

The Society of Korean Medicine Ophthalmology, Otolaryngology & Dermatology (대한한방안이비인후피부과학회)
권호 표지

A Research on Quality of Life and Cost of Oriental Medical Care in Adult Patients with Chronic Atopic Dermatitis in Korea

성인 만성 아토피 피부염 환자의 삶의 질과 한방 치료비용에 대한 고찰

  • 김남권 (원광대학교 한의과대학 안이비인후피부과학교실) ;
  • 오용열 (원광대학교 의과대학 산본병원 소화기내과) ;
  • 서은성 (원광대학교 한의과대학 안이비인후피부과학교실) ;
  • 이동효 (원광대학교 한의과대학 안이비인후피부과학교실)
  • Received : 2009.12.18
  • Accepted : 2009.12.30
  • Published : 2010.04.25
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : The aim of this study is to assess the impact of chronic atopic dermatitis (AD) on quality of life (QoL) as well as the economic burden associated with oriental medical treatment on adult patients with chronic AD in Korea. Methods : The EQ-5D health states, existence and duration of AD in the 2007 National Health and Nutrition Examination Survey (NHANES) were used to obtain the study subjects. A questionnaire including the questions on direct medical and direct non-medical costs associated with oriental medical treatment for adult patients with AD was specifically designed. Twenty-nine, members of the Korean Oriental Medical Ophthalmology, Otolaryngology and Dermatology Society (KOMOODS), completed the questionnaires. Results : The incidence of AD was around 3.09% in 2007 NHANES (sample survey, n=2981). Three months and above in duration of disease was 1.35%. The QoL data revealed as follows: 0.932 in non-chronic AD, 0.916 in chronic AD, and 0.908 in non-AD. We also stratified our analysis by age. The QoL data in 40's was statistically significant (P<0.023). But, no significant differences were reported in 20's, 30's, and 50's. The total direct medical costs of oriental medical treatment for AD was about 2,560,717 Won, and total direct non-medical costs was about 605,125 Won in a year. Conclusions : This study might be applied to find the evidence of economic evaluation in oriental medicine for AD. More rigorous studies are warranted.

Keywords

References

  1. Leung YMD. et al. Atopic dermatitis, IN: Freedberg IM, et al. Fitzpatrick's dermatology in general medicine, 6th ed. New York: McGraw-Hill. 2003;1190-94.
  2. 지혜미 등. 2006년 초등학생의 알레르기 질환 유병률의 전국적 역학조사, 소아알레르기 호흡기. 2009;19(2):165-72.
  3. Hon KI. et al. CDLQI, SCORAD and NESS: are they correlated? Qual Life Res. 2006;15:1551-58. https://doi.org/10.1007/s11136-006-0019-7
  4. Ben-Gashir MA. et al. Quality of life and disease severity are correlated in children with atopic dermaititis. Br J Dermatol. 2004;150:284-90. https://doi.org/10.1111/j.1365-2133.2004.05776.x
  5. 박창근 등. 유소아기 아토피피부염이 환아의 삶의 질과 가족에 미치는 영향. 대한피부과학회지. 2007;45(5):429-38.
  6. Ellis CN. et al. Cost of atopic dermatitis and eczema in the United State. J Am Acad Dermatol. 2002;46:361-70. https://doi.org/10.1067/mjd.2002.120528
  7. Racci G. et al. Atopic dermatitis in Italian children: evaluation of its economic impact. J Pediatr Health Care. 2006;20:311-15. https://doi.org/10.1016/j.pedhc.2006.04.009
  8. 양봉민. 보건경제학. 나남출판. 2006.
  9. Herman PM. et al. Is complementary and alternative medicine(CAM) cost-effective? a systematic review. BMC Complementary and Alternative Medicine. 2005;5(11).
  10. Lapidus CS, Kerr PE. "Social impact of atopic dermatitis", Med Health R I 2001;84:294-295
  11. Balkrishnan R, Housman TS, Carroll C, Feldman SR, Fleischer AB. Disease severity and associated family impact in childhood atopic dermatitis. Arch Dis Child . 2003;88:423-27. https://doi.org/10.1136/adc.88.5.423
  12. 보건복지가족부. 2007년 국민건강영양조사. 2007.
  13. 성상식 등. 한국인에서 EQ-5D를 이용한 건강 관련 삶의 질 측정. 대한류마티스학회지. 2004;11(3):254-62.
  14. Lundberg L. et al. Health-related Quality of Life in Patients with Psoriasis and Atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venerol. 2000;80:430-34. https://doi.org/10.1080/000155500300012873
  15. Gold MR. et al. Cost-Effectiveness in Health and Medicine. Oxford University Press. 1996.
  16. 김은정 등. 아토피피부염 환자의 삶의 질과 경제적 부담에 관한 연구. 대한피부과학회지. 2008;46(2):160-70.
  17. Drummond MF. et al. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press. 2006.
  18. Koopmanschap MA. PRODISQ : a modular questionnaire on productivity and disease for economic evaluation studies. Expert Rev Pharmacoecon Outcomes Res. 2005;5(1):23-28. https://doi.org/10.1586/14737167.5.1.23